Outcome of stroke patients on clopidogrel plus proton-pump inhibitors: a single-center cohort study

Insights

Co-prescribing clopidogrel with proton pump inhibitors (PPI) did not increase mortality risk in stroke patients. This combination was associated with lower 30-day unplanned readmission rates.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Recent studies indicate a potential increased risk of adverse cardiovascular events and mortality when clopidogrel is co-prescribed with proton pump inhibitors (PPIs).
  • This raises concerns regarding the safety of this common drug combination, particularly in vulnerable patient populations.

Purpose of the Study:

  • To investigate the impact of concomitant clopidogrel and PPI use on 30-day unplanned hospital readmissions and one-year all-cause mortality.
  • To compare outcomes between patients receiving clopidogrel with PPIs, clopidogrel with H2 blockers, and clopidogrel without gastric acid suppressants.

Main Methods:

  • A retrospective longitudinal cohort study was conducted at a single academic tertiary center.
  • Data from 464 patients admitted with stroke between 2010 and 2014 were analyzed.
  • Outcomes, including one-year mortality and 30-day unplanned readmissions, were compared using multivariable logistic regression.

Main Results:

  • Among 175 patients discharged on clopidogrel, 107 received PPIs and 36 received H2 blockers.
  • Clopidogrel plus PPI use was not associated with increased one-year mortality (6.2% vs. 4.8% in non-PPI cohort; OR 0.6, P=0.6).
  • The clopidogrel plus PPI group showed a significantly lower risk of 30-day unplanned readmission (OR 0.6, P=0.03).

Conclusions:

  • Concomitant use of clopidogrel and PPIs in stroke patients was not linked to higher mortality rates.
  • This drug combination was associated with reduced 30-day unplanned readmission rates.
  • Limitations include the single-center nature and retrospective design, precluding generalizability and analysis of treatment duration or compliance.
Abstract

Related Concept Videos

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
875
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.9K
Lattice Centering and Coordination Number02:33

Lattice Centering and Coordination Number

The structure of a crystalline solid, whether a metal or not, is best described by considering its simplest repeating unit, which is referred to as its unit cell. The unit cell consists of lattice points that represent the locations of atoms or ions. The entire structure then consists of this unit cell repeating in three dimensions. The three different types of unit cells present in the cubic lattice are illustrated in Figure 1.
Types of Unit Cells
Imagine taking a large number of identical...
11.5K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
ATP Driven Pumps III: V-type Pumps01:30

ATP Driven Pumps III: V-type Pumps

V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
4.7K
ATP Driven Pumps II: P-type Pumps01:34

ATP Driven Pumps II: P-type Pumps

The P-type pumps are a large family of integral membrane transporter ATPases. They are divided into five major types based on substrate specificity, from I to V.
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
6.2K